Umeå biotech firm Vakona has secured funding from existing and new investors to advance its innovative acne treatment targeting skin microbiome imbalances. This financing will help complete product development and prepare for clinical trials, aided by academic collaboration.
Roger Folkhage has been appointed CEO of Umeå-based Medicvent, succeeding Erik Lindström. He aims to drive international expansion in workplace safety and healthcare, leveraging his sales experience. Folkhage recognizes the company's potential for growth and innovation in air pollutant evacuation solutions.
Umeå Biotech Incubator (UBI) has received 2.5 million SEK from Kempestiftelserna for 2026 to support research verification activities. This funding aids commercialization for researchers, solidifying UBI's position as a leading biotech incubator in Europe.
Nil Medical's "Vestpack" is undergoing clinical trials in Sweden and Finland, aiming to improve treatment experiences for pediatric cancer patients. The company seeks a Business & Sales Manager to support expansion and is exploring further opportunities internationally.
QureTech Bio AB has received a European patent for GmPcides, a new class of synthetic antibacterials effective against drug-resistant bacteria like MRSA. This patent guarantees protection until 2041.
Mucocort AB has been granted a patent in Australia for its medical technology innovation. The company has successfully developed M045A, an innovative mucoadhesive "patch" for the treatment of oral aphthous ulcers.
Lina Olsson, former CEO of HiloProbe, has been appointed Business Unit Manager at Prevas in Umeå, where she will build up the local operations in MedTech and Life Science. The technology consultant firm Prevas aims to build a strong local team and tailor services to community needs.
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.